Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
to assess the long-term maintenance of efficacy of duloxetine 60 to 120 mg once daily (QD) compared with placebo by a comparison of the time to relapse among patients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revised (DSM-IV-TR)-defined generalized anxiety disorder (GAD) who responded to duloxetine during the open-label acute therapy phase after 22 to 26 weeks. Patients will be assessed for relapse during the 26- to 30-week double-blind continuation therapy phase.
Critère d'inclusion
- Generalized Anxiety Disorder